Developer docs
API playgroundTry for free, no card

Search company profiles

AIO-Studien-gGmbH

Full company profile

uuid0026x8f

Namestring
AIO-Studien-gGmbH
Legal namestring
AIO-Studien-gGmbH
Company typeenum
Private
Founded yearint
2007
Descriptiontext

AIO-Studien-gGmbH is a non-profit (gGmbH) academic clinical research organization based in Berlin that provides practical support to oncology investigators in the design, implementation and management of clinical trials in internal oncology. It operates as a subsidiary of the Deutsche Krebsgesellschaft e.V. (German Cancer Society) under the Arbeitsgemeinschaft Internistische Onkologie (AIO), one of the largest scientific working groups within the Society, and serves a community of Prüfärzte (clinical investigators) primarily in Germany with international collaborations.

Its core offering is end-to-end clinical trial coordination — connecting investigators with sponsors and funding, managing projects from conception through completion, providing legal, financial and specialist consultation, and coordinating with international partners and external service providers. The portfolio spans academic clinical trials, non-interventional observational studies, registries (including the CRISP real-world registry 2018–2024), translational laboratory studies, and secondary data use. Sub-products include a study database (Studiendatenbank), a publications repository (Publikationen), and the AIO-Studienakademie training platform. Notable trial outputs include ATOMIC (NEJM, 2026), PREDICT (British Journal of Cancer, 2025), and NintNivo (Lung Cancer, 2026).

Its business model is that of a non-profit professional services CRO: revenue is generated via coordination and sponsorship of clinical trials funded through grants, institutional support from the parent German Cancer Society, and partnerships with pharmaceutical sponsors and international research consortia. There is no traditional product pricing; services are delivered to investigators within the AIO network. The organization does not have external equity funding and does not disclose revenue, reflecting its charitable/public-benefit orientation. An emerging technology initiative — the AI Data Hub piloted with Innoplexus AG / Amrit AG (Partex N.V.) from March 2024 — adds AI-assisted data extraction and analysis on top of the coordination platform.

Short descriptiontext

AIO-Studien-gGmbH is a Berlin-based non-profit academic research organization and subsidiary of the Deutsche Krebsgesellschaft e.V. that coordinates and sponsors clinical trials in internal oncology for investigators within the AIO scientific working group, with growing international collaborations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial management, academic oncology research, investigator-initiated trials, clinical research organization, oncology study coordination
Industry4 codes
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Engineering, Accounting, Research, Management8700
Product category
Clinical Research Organization Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical trial sponsorship and coordination services
TypeProfessional Services
Description

As a subsidiary of the German Cancer Society, AIO-Studien-gGmbH operates as a non-profit academic research organization. Revenue appears to come from coordinating and sponsoring clinical trials, potentially through grants, institutional funding, and partnerships with pharmaceutical companies and research institutions.

aio-studien-ggmbh.de
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1AIO-Studienakademie
Description

An academy/project of AIO-Studien-gGmbH providing training and education in clinical research

aio-studien-ggmbh.de
Core offering1 text field

AIO-Studien-gGmbH provides practical support to clinical trial investigators (Pruefärzte) in the design, implementation, and management of academic clinical trials in internal oncology. Its team of project managers, coordinators, and study assistants guides research projects from conception through completion, connects investigators with sponsors and funders, and coordinates collaborations with international partners and external service providers. Complementary offerings include the AIO-Studienakademie training program and an AI-supported clinical data processing pilot.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AIO-Studien-gGmbH is a not-for-profit organization supporting academic research in internal oncology. The company offers a comprehensive portfolio centered on clinical trial support services, providing practical assistance to physicians in the design, implementation, and management of clinical trial projects. This core offering is complemented by a study database (Studiendatenbank) for tracking clinical studies, a publications repository (Publikationen) for disseminating research findings, and the AIO-Studienakademie for researcher education. The company manages and sponsors numerous clinical studies including the ATOMIC Phase III colon cancer trial, PREDICT pancreatic cancer study, and NintNivo lung cancer study. An emerging technology initiative is the AI Data Hub, a pilot project exploring AI-supported data processing for clinical research applications.

Product and service3 records
1Clinical Trial Support Services
CategoryClinical Research Organization Services
Description

End-to-end practical support for clinical trial investigators (Pruefärzte) covering study design, implementation, management, legal and financial consultation, and coordination with international partners and external service providers for academic clinical trials in internal oncology.

2AIO-Studienakademie
CategoryClinical Research Training
Description

Educational and training program providing professional development for clinical researchers within the AIO network, including retrospective review events (e.g., Rückblick 2025) covering study conduct and methodology.

3AI Data Hub
CategoryAI-enabled Clinical Data Services
Description

AI-supported data processing service for extracting, structuring, and analyzing clinical care and study data in oncology, developed as a pilot with Innoplexus AG/Amrit AG to enable efficient clinical research.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1AIO (Arbeitsgemeinschaft Internistische Onkologie)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AIO-Studien-gGmbH is a subsidiary of the German Cancer Society (Deutsche Krebsgesellschaft e.V.) and works closely with the AIO. The organization coordinates clinical trials and research projects under the AIO umbrella, with AIO representing one of the largest scientific working groups in the German Cancer Society. The partnership involves shared mission of promoting internal oncology through academic research.

aio-studien-ggmbh.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Coordinates collaborations with international partners across multiple clinical trials including the ATOMIC study (Alliance A021502) which involved international Phase III research in colon cancer. Participates in international data pooled analyses.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global commercial CRO with a dedicated oncology and early-phase practice. Comparable as a clinical trial service provider to biopharma, but operates at vastly larger scale and on a for-profit basis versus AIO-Studien-gGmbH's academic non-profit model.

TypeDirect peer
Description

Berlin-based academic research organization affiliated with Charité university hospital, conducting sponsor- and investigator-initiated clinical trials. Comparable geographic and structural profile, though broader in therapeutic area than AIO-Studien-gGmbH.

TypeDirect peer
Description

European non-profit ARO that designs, coordinates, and conducts clinical trials across multiple tumor types. Most directly comparable to AIO-Studien-gGmbH in mission, structure, and investigator-initiated trial focus, with a similar non-profit academic operating model.

TypeDirect peer
Description

German oncology ARO focused on gynecological cancers, part of the broader German oncology working-group ecosystem. Comparable as a disease-specific ARO with a society-backed operational company running investigator-initiated trials.

TypeBroad incumbent
Description

Global academic oncology network running translational and biomarker-driven trials. Comparable in academic-cooperative structure and oncology focus, but with a broader international (US/EU) footprint than AIO-Studien-gGmbH's DACH base.

6ETOP (European Thoracic Oncology Platform)
TypeDirect peer
Description

European non-profit cooperative group coordinating thoracic oncology trials across multiple countries. Comparable as a network-driven ARO conducting academic-led Phase II/III studies, similar in mission to AIO-Studien-gGmbH.

7IKF Klinische Krebsforschung GmbH (Interdisciplinary Center for Clinical Cancer Research)
TypeDirect peer
Description

German oncology-focused clinical research organization coordinating investigator-initiated trials. Operates a similar academic-ARO model with a society-aligned identity, making it a close functional peer in trial sponsorship and coordination.

8German Breast Group (GBG Forschungs GmbH)
TypeDirect peer
Description

German non-profit ARO focused on breast cancer clinical trials, operating under a similar gGmbH-style academic research organization model. Directly comparable in country, structure, and IIT-sponsorship mandate, though narrower in tumor-type scope.

TypeBroad incumbent
Description

Oncology division of one of the largest global commercial CROs. Represents the commercial-CRO counterpoint against which AIO-Studien-gGmbH competes for sponsor-led trials, with greater scale but less academic credibility.

TypeRegional player
Description

UK-based academic clinical trials unit running oncology IITs. Comparable in mission and academic-ARO model, but serves a different primary geography (UK/National Cancer Research Network) versus AIO-Studien-gGmbH's DACH focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AIO-Studien-gGmbH

Clinical Research Organization Servicesaio-studien-ggmbh.de

AIO-Studien-gGmbH is a Berlin-based non-profit academic research organization and subsidiary of the Deutsche Krebsgesellschaft e.V. that coordinates and sponsors clinical trials in internal oncology for investigators within the AIO scientific working group, with growing international collaborations.

What AIO-Studien-gGmbH does

AIO-Studien-gGmbH is a non-profit (gGmbH) academic clinical research organization based in Berlin that provides practical support to oncology investigators in the design, implementation and management of clinical trials in internal oncology. It operates as a subsidiary of the Deutsche Krebsgesellschaft e.V. (German Cancer Society) under the Arbeitsgemeinschaft Internistische Onkologie (AIO), one of the largest scientific working groups within the Society, and serves a community of Prüfärzte (clinical investigators) primarily in Germany with international collaborations.

Its core offering is end-to-end clinical trial coordination — connecting investigators with sponsors and funding, managing projects from conception through completion, providing legal, financial and specialist consultation, and coordinating with international partners and external service providers. The portfolio spans academic clinical trials, non-interventional observational studies, registries (including the CRISP real-world registry 2018–2024), translational laboratory studies, and secondary data use. Sub-products include a study database (Studiendatenbank), a publications repository (Publikationen), and the AIO-Studienakademie training platform. Notable trial outputs include ATOMIC (NEJM, 2026), PREDICT (British Journal of Cancer, 2025), and NintNivo (Lung Cancer, 2026).

Its business model is that of a non-profit professional services CRO: revenue is generated via coordination and sponsorship of clinical trials funded through grants, institutional support from the parent German Cancer Society, and partnerships with pharmaceutical sponsors and international research consortia. There is no traditional product pricing; services are delivered to investigators within the AIO network. The organization does not have external equity funding and does not disclose revenue, reflecting its charitable/public-benefit orientation. An emerging technology initiative — the AI Data Hub piloted with Innoplexus AG / Amrit AG (Partex N.V.) from March 2024 — adds AI-assisted data extraction and analysis on top of the coordination platform.

AIO-Studien-gGmbH firmographics

Firmographics
Name
AIO-Studien-gGmbH
Legal name
AIO-Studien-gGmbH
Website
https://aio-studien-ggmbh.de
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
AIO-Studien-gGmbH is a Berlin-based non-profit academic research organization and subsidiary of the Deutsche Krebsgesellschaft e.V. that coordinates and sponsors clinical trials in internal oncology for investigators within the AIO scientific working group, with growing international collaborations.
Ownership category
akta.pro rank

AIO-Studien-gGmbH industry classification

Industry
Product category
Clinical Research Organization Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical trial management
  • Academic oncology research
  • Investigator-initiated trials
  • Clinical research organization
  • Oncology study coordination

Where AIO-Studien-gGmbH is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

AIO-Studien-gGmbH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Clinical trial sponsorship and coordination services: As a subsidiary of the German Cancer Society, AIO-Studien-gGmbH operates as a non-profit academic research organization. Revenue appears to come from coordinating and sponsoring clinical trials, potentially through grants, institutional funding, and partnerships with pharmaceutical companies and research institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

AIO-Studien-gGmbH product offering

Product offering

Core offering

AIO-Studien-gGmbH provides practical support to clinical trial investigators (Pruefärzte) in the design, implementation, and management of academic clinical trials in internal oncology. Its team of project managers, coordinators, and study assistants guides research projects from conception through completion, connects investigators with sponsors and funders, and coordinates collaborations with international partners and external service providers. Complementary offerings include the AIO-Studienakademie training program and an AI-supported clinical data processing pilot.

Product overview

AIO-Studien-gGmbH is a not-for-profit organization supporting academic research in internal oncology. The company offers a comprehensive portfolio centered on clinical trial support services, providing practical assistance to physicians in the design, implementation, and management of clinical trial projects. This core offering is complemented by a study database (Studiendatenbank) for tracking clinical studies, a publications repository (Publikationen) for disseminating research findings, and the AIO-Studienakademie for researcher education. The company manages and sponsors numerous clinical studies including the ATOMIC Phase III colon cancer trial, PREDICT pancreatic cancer study, and NintNivo lung cancer study. An emerging technology initiative is the AI Data Hub, a pilot project exploring AI-supported data processing for clinical research applications.

Differentiator

Problem solved

Functional benefit

Brands

  • AIO-Studienakademie: An academy/project of AIO-Studien-gGmbH providing training and education in clinical research

Products and services

  • Clinical Trial Support Services End-to-end practical support for clinical trial investigators (Pruefärzte) covering study design, implementation, management, legal and financial consultation, and coordination with international partners and external service providers for academic clinical trials in internal oncology.
  • AIO-Studienakademie Educational and training program providing professional development for clinical researchers within the AIO network, including retrospective review events (e.g., Rückblick 2025) covering study conduct and methodology.
  • AI Data Hub AI-supported data processing service for extracting, structuring, and analyzing clinical care and study data in oncology, developed as a pilot with Innoplexus AG/Amrit AG to enable efficient clinical research.

Companies that use AIO-Studien-gGmbH

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

AIO-Studien-gGmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature1 record

AIO-Studien-gGmbH partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • AIO (Arbeitsgemeinschaft Internistische Onkologie)coreStrategic or Co-development PartnerAIO-Studien-gGmbH is a subsidiary of the German Cancer Society (Deutsche Krebsgesellschaft e.V.) and works closely with the AIO. The organization coordinates clinical trials and research projects under the AIO umbrella, with AIO representing one of the largest scientific working groups in the German Cancer Society. The partnership involves shared mission of promoting internal oncology through academic research.
  • International PartnerscoreStrategic or Co-development PartnerCoordinates collaborations with international partners across multiple clinical trials including the ATOMIC study (Alliance A021502) which involved international Phase III research in colon cancer. Participates in international data pooled analyses.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

AIO-Studien-gGmbH competitors and assessment

Company assessment

Broad incumbents

  • Parexel International: Global commercial CRO with a dedicated oncology and early-phase practice. Comparable as a clinical trial service provider to biopharma, but operates at vastly larger scale and on a for-profit basis versus AIO-Studien-gGmbH's academic non-profit model.
  • WIN Consortium (Worldwide Innovative Network for personalized cancer medicine): Global academic oncology network running translational and biomarker-driven trials. Comparable in academic-cooperative structure and oncology focus, but with a broader international (US/EU) footprint than AIO-Studien-gGmbH's DACH base.
  • IQVIA Oncology: Oncology division of one of the largest global commercial CROs. Represents the commercial-CRO counterpoint against which AIO-Studien-gGmbH competes for sponsor-led trials, with greater scale but less academic credibility.

Direct peers

  • Charité Research Organisation GmbH: Berlin-based academic research organization affiliated with Charité university hospital, conducting sponsor- and investigator-initiated clinical trials. Comparable geographic and structural profile, though broader in therapeutic area than AIO-Studien-gGmbH.
  • EORTC (European Organisation for Research and Treatment of Cancer): European non-profit ARO that designs, coordinates, and conducts clinical trials across multiple tumor types. Most directly comparable to AIO-Studien-gGmbH in mission, structure, and investigator-initiated trial focus, with a similar non-profit academic operating model.
  • AGO Research GmbH (Arbeitsgemeinschaft Gynäkologische Onkologie): German oncology ARO focused on gynecological cancers, part of the broader German oncology working-group ecosystem. Comparable as a disease-specific ARO with a society-backed operational company running investigator-initiated trials.
  • ETOP (European Thoracic Oncology Platform): European non-profit cooperative group coordinating thoracic oncology trials across multiple countries. Comparable as a network-driven ARO conducting academic-led Phase II/III studies, similar in mission to AIO-Studien-gGmbH.
  • IKF Klinische Krebsforschung GmbH (Interdisciplinary Center for Clinical Cancer Research): German oncology-focused clinical research organization coordinating investigator-initiated trials. Operates a similar academic-ARO model with a society-aligned identity, making it a close functional peer in trial sponsorship and coordination.
  • German Breast Group (GBG Forschungs GmbH): German non-profit ARO focused on breast cancer clinical trials, operating under a similar gGmbH-style academic research organization model. Directly comparable in country, structure, and IIT-sponsorship mandate, though narrower in tumor-type scope.

Regional players

  • Cancer Research UK Clinical Trials Unit: UK-based academic clinical trials unit running oncology IITs. Comparable in mission and academic-ARO model, but serves a different primary geography (UK/National Cancer Research Network) versus AIO-Studien-gGmbH's DACH focus.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

AIO-Studien-gGmbH social profiles

Digital presence

AIO-Studien-gGmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AIO-Studien-gGmbH leadership team

Management profile

Number of profiles

Profiles1 record

AIO-Studien-gGmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AIO-Studien-gGmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIO-Studien-gGmbH

What does AIO-Studien-gGmbH do?

AIO-Studien-gGmbH provides practical support to clinical trial investigators (Pruefärzte) in the design, implementation, and management of academic clinical trials in internal oncology. Its team of project managers, coordinators, and study assistants guides research projects from conception through completion, connects investigators with sponsors and funders, and coordinates collaborations with international partners and external service providers. Complementary offerings include the AIO-Studienakademie training program and an AI-supported clinical data processing pilot.

Is AIO-Studien-gGmbH a public or private company?

AIO-Studien-gGmbH is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was AIO-Studien-gGmbH founded?

AIO-Studien-gGmbH was founded in 2007. It employs 11 to 50 people.

Where is AIO-Studien-gGmbH based?

AIO-Studien-gGmbH is headquartered in Berlin, Germany, in the Europe region.

How does AIO-Studien-gGmbH make money?

One revenue line is on record: clinical trial sponsorship and coordination services.

Who are AIO-Studien-gGmbH's main competitors?

Broad incumbents on record are Parexel International, WIN Consortium (Worldwide Innovative Network for personalized cancer medicine) and IQVIA Oncology. Direct peers are Charité Research Organisation GmbH, EORTC (European Organisation for Research and Treatment of Cancer), AGO Research GmbH (Arbeitsgemeinschaft Gynäkologische Onkologie), ETOP (European Thoracic Oncology Platform), IKF Klinische Krebsforschung GmbH (Interdisciplinary Center for Clinical Cancer Research) and German Breast Group (GBG Forschungs GmbH). Cancer Research UK Clinical Trials Unit is listed as a regional player.

Does AIO-Studien-gGmbH have an API?

No public API is recorded for AIO-Studien-gGmbH.

What industry is AIO-Studien-gGmbH in?

AIO-Studien-gGmbH's product category is Clinical Research Organization Services. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGACAF, Investigator & Site Training / GCP Support. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales